[Study on the chronic toxicity of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane(talinolol, Cordanum, 02-115) in the rat and the beagle].
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000633:toxicity*; D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D001772:Blood Cell Count; D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight / Q000187:drug effects; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004702:Endocrine Glands / Q000187:drug effects; D005260:Female; D006321:Heart / Q000187:drug effects; D006452:Hemoglobinometry; D008168:Lung / Q000187:drug effects; D008297:Male; D011412:Propanolamines / Q000008:administration & dosage / Q000633:toxicity*; D051381:Rats; D013154:Spleen / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D001786:Blood Glucose; D011412:Propanolamines; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase
Chronische Toxizitätsprfung von 1-[4-Cyclohexylureidophenoxy]-2-hydroxy-3-tert.-butylaminopropan (Talinolol, Cordanum, 02-115) an Ratte und Beagle-Hund